We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Latest Product News
Havn Life Sciences To Supply Psychedelics to Clinical Studies Focused on Veterans and PTSD
Product News

Havn Life Sciences To Supply Psychedelics to Clinical Studies Focused on Veterans and PTSD

Havn Life Sciences Inc. a biotechnology company, announced it has signed a Memorandum of Agreement (“MOA”) with the international veterans organization, Heroic Hearts Project.
CYBIN Signs Definitive Agreement to Acquire Adelia Therapeutics
Product News

CYBIN Signs Definitive Agreement to Acquire Adelia Therapeutics

Cybin Inc. today announced the signing of a definitive agreement to acquire 100% of the shares in Adelia Therapeutics Inc.
BioMed X Institute Completes First Research Project in Neuroscience
Product News

BioMed X Institute Completes First Research Project in Neuroscience

BioMed X announces the successful completion of its first joint research project with Boehringer Ingelheim in neuroscience.
Fujirebio Diagnostics Files 510(k) with FDA For Lumipulse G β-Amyloid Ratio
Product News

Fujirebio Diagnostics Files 510(k) with FDA For Lumipulse G β-Amyloid Ratio

Fujirebio Diagnostics, Inc. today announced that it has filed its Lumipulse® G β-Amyloid Ratio (1-42/1-40) in vitro diagnostic test with the FDA.
MOBILion and International Research Team are Awarded Grant for Research in Parkinson's Disease
Product News

MOBILion and International Research Team are Awarded Grant for Research in Parkinson's Disease

MOBILion Systems is collaborating with an international research team to identify alterations in the metabolism of selective glycosphingolipids in the brain.
Movers and Shakers in Biobusiness Report
Product News

Movers and Shakers in Biobusiness Report

The seventh annual Movers and Shakers in BioBusiness report highlights 30 examples of resourceful leaders in the UK bioscience sector.
PerkinElmer Launches No-Wash Immunoassay for Neuroscience Disease and Therapeutics Research
Product News

PerkinElmer Launches No-Wash Immunoassay for Neuroscience Disease and Therapeutics Research

PerkinElmer, Inc., today launched the life science industry’s first no-wash Ubiquitin phosphorylation at Serine 65 immunoassay that is aimed at helping scientists discover new therapeutic candidates earlier in the disease cycle.
Impel Neuropharma Presents Data for the 2020 Migraine Trust Virtual Symposium
Product News

Impel Neuropharma Presents Data for the 2020 Migraine Trust Virtual Symposium

Impel NeuroPharma announced that it has presented patient-reported outcomes data from the Company’s pivotal Phase 3, open-label study “STOP 301” of INP104 (dihydroergotamine mesylate) or DHE using the company’s proprietary POD technology, for the treatment of acute migraine in an oral presentation at the Migraine Trust Virtual Symposium (MTIS) to be held from October 3-9, 2020.
CZI Awards $4.5M to Advance Innovative Approaches to Fighting Neurodegenerative Diseases
Product News

CZI Awards $4.5M to Advance Innovative Approaches to Fighting Neurodegenerative Diseases

The Chan Zuckerberg Initiative has announced $4.5 million in funding to support 30 pairs of researchers to collaborate and apply novel approaches for gaining greater insight into neurodegenerative disorders.
Cobra Biologics Delivers Final Plasmids for Production of CG01 in CombiGene's Epilepsy Project
Product News

Cobra Biologics Delivers Final Plasmids for Production of CG01 in CombiGene's Epilepsy Project

The milestone in the project paves the way for production of novel gene therapy drug candidate designed to treat drug-resistant focal epilepsy.
Advertisement